文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Hongshan Li
发表
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Liang Zhao, Hui Zhang, Richard Pazdur, 2015, Clinical Cancer Research.